Slowing the progression of aortic stenosis

Kameswari Maganti, Nalini Rajamannan*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Aortic stenosis (AS) is the most frequent valvular heart disease in the Western world. The only definitive treatment for this disorder is surgical replacement of the aortic valve. Recent histopathologic studies have provided important insights into the pathogenesis of calcific AS. These results suggest that this disease develops as the result of an active disease process at the cellular and molecular levels that shares many similarities with vascular atherosclerosis, ranging from endothelial dysfunction to, ultimately, calcification. In this review, we discuss the cellular and molecular mechanisms, natural history, diagnosis, and therapeutic options, including the potential for medical therapies, for the treatment of AS.

Original languageEnglish (US)
Pages (from-to)18-26
Number of pages9
JournalCurrent Treatment Options in Cardiovascular Medicine
Issue number1
StatePublished - Feb 2008

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Slowing the progression of aortic stenosis'. Together they form a unique fingerprint.

Cite this